Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Half Year 2025 Trading Update

22 May 2025 07:00

RNS Number : 6782J
IDOX PLC
22 May 2025
 

22 May 2025

Idox plc

('Idox' or the 'Group' or the 'Company')

Half Year 2025 Trading Update

Positive momentum continues with good first half performance

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, today issues a trading update for its financial half year ended 30 April 2025 ('FY25 H1').

Group trading performance

 

We are pleased to report that the Group has delivered good growth during the first six months of the year, generating overall revenue of c.£45.0m (HY24: £43.1m). The Group delivered solid recurring revenue growth of c.9% which was partially offset, as anticipated, by lower non-recurring revenue. Adjusted EBITDA1 increased by over 6% to c.£13.9m (HY24: £13.1m), in line with the Board's expectations.

 

The Group recorded a c.9% increase in order intake to c.£59.0m (HY24: £54.1m) with key new wins for the Assets division and our geospatial data solutions, providing increased levels of recurring revenue visibility across all divisions for the remainder of FY25 and into FY26.

 

The Group continued to generate strong cash flows during the period and ended the half with a net cash2 position of c.£0.2m compared to a net debt position of £9.9m as at 31 October 2024. 

 

David Meaden, Chief Executive Officer of Idox commented:

 

"The Group has delivered a positive performance during the first half, in line with the Board's expectations, with good revenue and adjusted EBITDA growth as well as solid order intake providing good future visibility.

 

We have significantly reduced our net debt since the end of FY24 to a net cash position as we continue to drive positive cash performance in the business.

 

Our M&A pipeline is healthy, and we were pleased to complete the acquisition of Plianz shortly after the half year end to strengthen our existing Social Care offering and build on our strong public sector software capabilities. We remain confident of adding to our existing portfolio of specialist software and geospatial data solutions to deliver further profitable growth.

 

We are pleased with our progress and positive momentum and are confident that Idox is well positioned for growth in the remainder of 2025."

 

Notice of half year results

 

The Group expects to report its FY25 H1 results on Thursday 12 June 2025. Management will host a results webinar on the day. Please contact MHP to register your interest.

 

1 Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

2 Net cash / (debt) is defined as the aggregation of cash, bank borrowings and long-term bond. This differs from a similar measure under IFRS, which would also include lease liabilities as debt. The definition used is consistent with that used within the Group's banking arrangements.

 

 

For further information please contact:

 

Idox plc

+44 (0) 333 011 1200

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive Officer

 

Anoop Kang, Chief Financial Officer

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Benjamin Cryer

 

Kate Bannatyne

 

Adam Telling

MHP

+ 44 (0) 7855 447944

Reg Hoare

 idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

Finn Taylor

For more information see www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGZKNMMGKZM
Date   Source Headline
29th May 20267:00 amRNSCancellation - IDOX Plc
26th May 20261:45 pmRNSRule 19.6(b) update
18th May 202610:22 amRNSHolding(s) in Company
12th May 20268:21 amRNSCompulsory Acquisition of Idox Shares
7th May 20263:52 pmRNSHolding(s) in Company
5th May 20267:00 amRNSAcceptance Level Update
28th Apr 20266:00 pmRNSIDOX
28th Apr 20267:00 amRNSProposed cancellation of Idox shares on AIM
27th Apr 20267:00 amRNSAcceptance Level Update
22nd Apr 20262:26 pmRNSForm 8.3 - Idox plc
22nd Apr 20261:00 pmRNSReplacement: Director/PDMR Shareholding
22nd Apr 202611:24 amRNSDirector/PDMR Shareholding
21st Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
21st Apr 20269:13 amBUSForm 8.3 - [IDOX PLC - 20 04 2026] - (CGWL)
21st Apr 20267:45 amRNSDisclosure Table
21st Apr 20267:00 amRNSOffer Declared Unconditional
20th Apr 20263:46 pmRNSUpdate on Letters of Intent
20th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
20th Apr 20269:12 amBUSForm 8.3 - [IDOX PLC - 17 04 2026] - (CGWL)
20th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20263:26 pmRNSForm 8.3 - IDOX PLC
17th Apr 20263:25 pmRNSForm 8.3 - Idox plc
17th Apr 20262:10 pmRNSHolding(s) in Company
17th Apr 20261:03 pmRNSForm 8.3 - IDOX PLC
17th Apr 202612:43 pmRNSForm 8.3 - Idox plc
17th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
17th Apr 20269:05 amBUSForm 8.3 - [IDOX PLC - 16 04 2026] - (CGWL)
17th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20267:00 amRNSForm 8.3 - Idox plc
16th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:12 pmRNSForm 8.3 - Idox plc
16th Apr 20261:15 pmRNSForm 8.3 - IDOX PLC
16th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
16th Apr 20268:51 amBUSForm 8.3 - [IDOX PLC - 15 04 2026] - (CGWL)
16th Apr 20267:00 amRNSSatisfaction of Regulatory Conditions
15th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
15th Apr 20262:38 pmRNSForm 8.3 - Idox plc
15th Apr 20269:25 amBUSForm 8.3 - [IDOX PLC - 14 04 2026] - (CGWL)
15th Apr 20267:00 amRNSUpdate on Letters of Intent
14th Apr 20264:01 pmRNSForm 8.3 - Idox plc
14th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
14th Apr 20261:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 202612:37 pmRNSForm 8.3 - Idox plc
14th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
14th Apr 202610:04 amBUSForm 8.3 - [IDOX PLC - 13 04 2026] - (CGWL)
14th Apr 20267:00 amRNSUpdate on Letters of Intent
13th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
13th Apr 202610:46 amBUSForm 8.3 - [IDOX PLC - 10 04 2026] - (CGWL)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.